K36 Therapeutics, Inc. (“K36”), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor …
![Dr. Benjamin Winograd - Chief Medical Officer at K36 Therapeutics](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-edward-jenner-4031442.jpg?resize=760%2C427&ssl=1)
![Dr. Benjamin Winograd - Chief Medical Officer at K36 Therapeutics](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-edward-jenner-4031442.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
K36 Therapeutics, Inc. (“K36”), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor …